JD.com and Expedia-backed online travel agency Traveloka has picked up $250m in funding led by an undisclosed investor that could be Qatar Investment Authority.
Month: July 2020
Ro rides $200m funding wave
Forbes-backed online pharmacy Ro has received $200m in funding led by General Catalyst, trebling its valuation to $1.5bn.
Thought Machine reworks series B
Thought Machine has added $42m to its series B round, bringing its total to $125m and welcoming SEB as a new investor.
CureVac files for IPO
GlaxoSmithKline is in line for an exit as CureVac files for an initial public offering in the US, 20 years after being spun out of Eberhard Karls University of Tübingen.
Hughes Network connects to OneWeb
Existing backer Hughes Network Systems has committed $50m to join Bharti Enterprises and the UK government in acquiring the bankrupt satellite internet services provider.
Everphone calls up investors for $40m
Deutsche Telekom has invested in Everphone’s series B round as the company expects a shift to remote work will bolster demand for its device leasing service.
Enthera enters $32.8m series A round
AbbVie Ventures and Sofinnova Partners have co-led a series A round for Enthera Pharmaceuticals, which is using stem cells to treat autoimmune disorders.
EMQ engages Digital Garage for $20m series B
Digital Garage has contributed to a $20m series B round for EMQ, which will use the cash to drive international growth for its cross-border payment network.
Celsius Network decrypts fresh coin
Backed by Tether International, Celsius Network offers crypto-secured loans without a credit check denominated in US dollars.
Technique Solaire takes $29m
Credit Agricole returned to reinvest in the solar and biomethane project developer having contributed to a $122m debt round in May.
Creek & River seeks applicants for incubator
The creative studio and 01Booster’s four-month joint venture will help grow the entrepreneurial ecosystem in the Japanese city of Fukushima and environs.
Sidecar Health loads up $20m round
Sidecar Health, which offers health insurance billed through a debit card, attracted Comcast Ventures to a round that brought its funding total to $40m.
No time to hide heads
It is an unpleasant term and practice but the so-called brain rape of another company’s technology or ideas is part of the challenge of doing business.
Nurix negotiates $209m IPO
Nurix Therapeutics, a Celgene-backed cancer treatment developer based on UC Berkeley and San Francisco research, priced shares above its range to raise $209m.